Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
7 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The fund said its unaudited half-year results were for the six months ended 30 June 2026. Ordinary share NAV per share was US$2.393 at 30 June 2026, up 58% from US$1.510 at 31 December 2025.
The AIM-listed UK technology group reported six-month revenue of £9.2m, adjusted EBITDA of £1.0m and adjusted profit before tax of £0.5m. It also said it secured about £1.6m of additional debt funding after period end.
The food and agri group said revenue rose 33% in Q2 to US$1,139 million and 32% in 6M to US$2,161 million. Net profit fell 35% in Q2 to US$28 million.
For best results when printing this announcement, please click on link below: RNS Number: 0622W BioPharma Credit PLC 24 September 2026 24 September 2026 BIOPHARMA CREDIT PLC ("BPCR" or "the Company") HALF YEAR REPORT FOR THE YEAR ENDED 30 JUNE 2026 BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt inv
US Treasury plans to sell USD-denominated 3-year and 5-year notes.
European economic schedule for Thursday, June 25th, 2026, includes releases from Japan, Germany, France, and the US.
The European economic schedule for Wednesday, June 24th, 2026, includes various economic data releases and central bank decisions.